The sensation of stinging or burning experienced upon instilling ophthalmic solutions is a common occurrence. This discomfort stems from a variety of factors related to the composition of the drops themselves and the physiological state of the ocular surface. Understanding these elements is key to mitigating patient discomfort and ensuring adherence to prescribed treatments.
The significance of addressing ocular irritation is paramount in maintaining patient compliance. Burning or stinging can deter individuals from consistently using their prescribed medications, potentially compromising treatment efficacy. Minimizing these sensations is crucial for effective long-term management of various ocular conditions. Historically, formulation advancements have focused on improving tolerability alongside therapeutic efficacy.
The following discussion will delve into the primary causes of transient discomfort associated with the introduction of these solutions into the eye, considering aspects such as pH, osmolarity, preservatives, active ingredients, and pre-existing ocular surface conditions.
1. pH Imbalance
The human tear film maintains a relatively narrow pH range, typically around 7.4, which is considered neutral to slightly alkaline. When an ophthalmic solution possessing a significantly different pH is instilled, it disrupts this delicate balance, leading to a sensation of burning or stinging. This occurs because the corneal nerve endings, which are responsible for pain and sensation, are highly sensitive to pH changes. The greater the deviation from the natural tear film pH, the more intense the burning sensation is likely to be. This is a primary contributing factor to discomfort experienced upon eye drop application. As a component of “why does eye drops burn”, pH imbalance plays a crucial role in determining the tolerability of the formulation.
For instance, if an eye drop has a pH of 5.0 (acidic) or 9.0 (alkaline), the eye will attempt to buffer the solution and restore its natural pH. This buffering process, while essential, can temporarily irritate the ocular surface. Real-life examples include older formulations of certain glaucoma medications which had suboptimal pH levels, resulting in significant patient complaints of burning and stinging. Modern formulations often incorporate buffering agents to bring the pH closer to that of the tear film, thereby minimizing irritation. Understanding this pH-related discomfort is practically significant because it guides pharmaceutical companies in developing more comfortable and tolerable eye drops, thereby improving patient adherence.
In summary, the stinging or burning sensation associated with eye drops can often be directly attributed to pH imbalance. The degree of discomfort is generally proportional to the difference between the solution’s pH and that of the natural tear film. Addressing this issue through careful formulation, including the use of buffering agents, is essential for enhancing patient comfort and ensuring successful treatment outcomes. This also relates back to more general formulations of eye drops, especially those meant to be used for long durations, because even minor acidity or alkalinity will cause irritation that is non-tenable.
2. Osmolarity Differences
Osmolarity, referring to the solute concentration of a solution, plays a crucial role in ocular comfort. A significant disparity in osmolarity between an ophthalmic solution and the natural tear film is a primary contributor to transient burning upon instillation. If a solution is hyperosmolar (higher solute concentration than tears), it draws fluid from the corneal and conjunctival cells, leading to cellular dehydration and irritation. Conversely, a hypoosmolar solution (lower solute concentration than tears) causes fluid to enter the cells, potentially resulting in swelling. Either scenario stimulates corneal nerve endings, triggering the sensation of stinging or burning. This aspect of “why does eye drops burn” highlights the importance of maintaining an appropriate osmotic balance for optimal tolerability.
Examples illustrating this principle are abundant in clinical practice. In individuals with dry eye disease, the tear film is often hyperosmolar. Instilling a hyperosmolar eye drop in such cases exacerbates the existing condition, intensifying the burning sensation. Furthermore, certain preserved eye drops may exhibit higher osmolarity levels due to the addition of solutes alongside the active pharmaceutical ingredient. Conversely, specially formulated hypotonic eye drops are sometimes prescribed to alleviate discomfort associated with hyperosmolar dry eye conditions. The practical application of this understanding lies in the development of more physiologic formulations closely matching the osmolarity of natural tears, typically around 300 mOsm/L. This includes the use of agents like sodium chloride or mannitol to adjust osmolarity.
In conclusion, the osmotic balance of ophthalmic solutions is a critical determinant of ocular comfort. Discrepancies in osmolarity between the eye drop and the tear film directly contribute to the burning sensation experienced by patients. Addressing this issue through meticulous formulation and the development of osmoprotective agents is crucial for minimizing discomfort, improving patient compliance, and ultimately ensuring successful therapeutic outcomes. Further research into osmoprotective substances and their incorporation into eye drop formulations holds promise for enhancing tolerability and treatment adherence.
3. Preservative Sensitivity
Preservative sensitivity represents a significant factor contributing to ocular surface irritation and the subjective experience of burning upon instillation of ophthalmic solutions. Many eye drops incorporate preservatives to maintain sterility and prevent microbial contamination, particularly in multi-dose containers. However, these agents can disrupt the integrity of the tear film and epithelial cells, leading to inflammation and discomfort.
-
Benzalkonium Chloride (BAK) Toxicity
Benzalkonium chloride (BAK) is a commonly used preservative in eye drops. While effective as an antimicrobial agent, BAK exhibits cytotoxic properties, disrupting the lipid layer of the tear film and causing epithelial cell damage. Chronic exposure to BAK has been associated with increased tear film instability, ocular surface inflammation, and exacerbation of dry eye symptoms. The damage to corneal nerve endings results in the burning sensation patients experience, a direct link to why eye drops burn. Real-life examples include patients on long-term glaucoma medications containing BAK, who often report significant ocular discomfort, impacting treatment adherence.
-
Alternative Preservatives and Their Effects
Recognizing the limitations of BAK, alternative preservatives such as stabilized oxychloro complex (Purite) and sodium perborate have been developed. Purite dissociates into naturally occurring tear components upon contact with the eye, reducing its potential for toxicity. Sodium perborate breaks down into hydrogen peroxide and water, minimizing long-term exposure to a toxic preservative. However, even these alternatives can elicit irritation in sensitive individuals, albeit generally to a lesser extent than BAK. Some patients may still report a mild burning sensation upon instillation, highlighting the inherent challenge of balancing preservative efficacy with ocular tolerability.
-
Preservative-Free Formulations
Preservative-free eye drops represent a significant advancement in minimizing ocular surface toxicity. These formulations are typically packaged in single-use vials to maintain sterility without the need for preservatives. Preservative-free options are particularly beneficial for patients requiring frequent or long-term eye drop use, such as those with chronic dry eye or glaucoma. While preservative-free formulations eliminate preservative-related burning, the active ingredient itself may still cause some degree of transient discomfort in some individuals, although it is significantly less in most cases.
-
Individual Sensitivity and Allergic Reactions
Individual susceptibility to preservatives varies significantly. Some individuals may tolerate BAK well, while others experience pronounced irritation and allergic reactions. Allergic reactions to preservatives can manifest as itching, redness, swelling, and increased tearing, in addition to the burning sensation. Diagnosing preservative sensitivity typically involves a careful history, clinical examination, and, in some cases, allergy testing. Management strategies include switching to preservative-free formulations or using eye drops with alternative, less toxic preservatives. It is important to consider patient history to rule out hypersensitivity, so as to reduce any possibility of irritation.
In summary, preservative sensitivity is a critical consideration in understanding why eye drops burn. The choice of preservative, its concentration, and the frequency of eye drop use all contribute to the potential for ocular surface irritation. Preservative-free formulations offer a valuable alternative for minimizing preservative-related toxicity. By understanding the nuances of preservative sensitivity, clinicians can tailor treatment regimens to optimize patient comfort and adherence, ultimately improving therapeutic outcomes. Furthermore, new preservative methodologies are being researched to further reduce patient irritation from formulations.
4. Active Ingredient Irritation
The inherent properties of certain active pharmaceutical ingredients (APIs) within ophthalmic solutions can directly contribute to the stinging or burning sensation experienced upon instillation. Even when pH and osmolarity are carefully controlled, the API itself can interact with the ocular surface, triggering irritation and discomfort.
-
Direct Corneal Nerve Stimulation
Some APIs possess the capacity to directly stimulate corneal nerve endings, irrespective of pH or osmolarity. This stimulation can manifest as a sharp, transient burning sensation. For instance, certain antiviral agents used to treat herpetic keratitis can directly activate nociceptors on the corneal surface, leading to significant discomfort. Similarly, some nonsteroidal anti-inflammatory drugs (NSAIDs) used post-cataract surgery may cause transient burning due to their direct interaction with corneal nerve fibers. These examples underscore how the chemical structure of the API can inherently contribute to ocular irritation, independent of other formulation factors.
-
Disruption of the Tear Film
Certain APIs can disrupt the tear film’s delicate balance, leading to evaporative dry eye and subsequent irritation. For example, some beta-blockers used to treat glaucoma can reduce tear production, contributing to a dry eye state and exacerbating any burning sensation upon instillation. This disruption occurs because the API interferes with the normal function of lacrimal gland cells. The resultant tear film instability exposes the corneal surface to environmental stressors, increasing the likelihood of irritation and discomfort. Understanding this mechanism is crucial in managing patients on medications known to impact tear film stability.
-
Inflammatory Cascade Activation
Specific APIs can trigger an inflammatory cascade on the ocular surface. This cascade involves the release of inflammatory mediators, such as cytokines and prostaglandins, which sensitize corneal nerve endings and amplify the sensation of burning. For instance, some prostaglandin analogs used in glaucoma management can induce a mild inflammatory response in the conjunctiva, leading to redness, itching, and a burning sensation. While these inflammatory effects are often mild, they can contribute to patient discomfort and impact treatment adherence, further explaining why eye drops burn.
-
Vehicle Interactions
The vehicle, or inactive ingredients, used to deliver the API can also influence the degree of irritation experienced. Certain vehicles may enhance the penetration of the API into the corneal tissue, leading to increased nerve stimulation and burning. For example, vehicles containing penetration enhancers, while improving drug delivery, can also increase the potential for irritation. Formulations with high viscosity may also cause blurring and subsequent discomfort. Therefore, the choice of vehicle is crucial in mitigating API-related irritation and ensuring patient comfort. Balancing effective drug delivery with minimal irritation is a key consideration in ophthalmic formulation development.
In conclusion, the inherent properties of active ingredients represent a significant component of why eye drops burn. The potential for direct nerve stimulation, tear film disruption, inflammatory cascade activation, and vehicle interactions all contribute to the overall tolerability of ophthalmic solutions. Careful selection of APIs, optimized formulation strategies, and consideration of individual patient sensitivities are essential in minimizing active ingredient-related irritation and improving patient compliance. This also highlights the need for new formulations and delivery mechanisms to reduce discomfort, such as incorporating nanotechnology.
5. Ocular surface condition
The pre-existing state of the ocular surface significantly influences the degree of discomfort experienced upon instillation of ophthalmic solutions. Compromised ocular surface integrity amplifies the sensation of burning, making patients with certain conditions particularly susceptible to irritation. An understanding of these conditions is therefore crucial in addressing the multifaceted issue of why eye drops burn. This section explores the key ocular surface conditions contributing to increased sensitivity.
-
Dry Eye Disease
Dry eye disease, characterized by tear film instability and ocular surface inflammation, is a primary factor increasing the likelihood of burning upon eye drop instillation. In dry eye, the tear film’s protective function is compromised, exposing the corneal epithelium to environmental stressors and increasing its vulnerability to irritants within ophthalmic solutions. The hyperosmolarity of the tear film in dry eye patients further exacerbates the burning sensation, as any deviation in osmolarity from the instilled solution causes increased discomfort. Additionally, the reduced tear volume limits the dilution and clearance of the eye drops, prolonging contact time and potentially increasing irritation. Patients with dry eye frequently report more intense and prolonged burning sensations compared to individuals with healthy tear films. The severity of dry eye symptoms is often directly correlated with the degree of burning experienced after eye drop administration.
-
Blepharitis and Meibomian Gland Dysfunction (MGD)
Blepharitis, an inflammation of the eyelids, and Meibomian Gland Dysfunction (MGD), a condition affecting the oil-producing glands in the eyelids, can both contribute to increased ocular surface sensitivity. Blepharitis often leads to the release of inflammatory mediators onto the ocular surface, sensitizing corneal nerve endings and increasing their reactivity to eye drop components. MGD results in a deficiency of the lipid layer of the tear film, leading to increased tear evaporation and subsequent corneal exposure. This exposure, combined with the inflammatory environment associated with blepharitis, makes the ocular surface more vulnerable to irritation from preservatives, active ingredients, and vehicle components within eye drops. Patients with these conditions often experience a more pronounced burning sensation upon instillation, as the compromised ocular surface lacks its normal protective mechanisms.
-
Corneal Abrasions and Epithelial Defects
The presence of corneal abrasions or epithelial defects dramatically increases the sensitivity of the ocular surface to eye drops. These defects disrupt the intact corneal epithelium, exposing underlying nerve endings and rendering them highly susceptible to stimulation by components within ophthalmic solutions. Even solutions with minimal irritant potential can elicit a significant burning sensation when applied to a cornea with compromised epithelial integrity. Furthermore, the healing process of these defects can be slowed by certain preservatives or active ingredients, prolonging discomfort and potentially delaying recovery. Management strategies for patients with corneal abrasions or epithelial defects often involve using preservative-free eye drops and lubricating agents to minimize irritation and promote healing.
-
Allergic Conjunctivitis
Allergic conjunctivitis, characterized by inflammation of the conjunctiva due to an allergic reaction, significantly increases ocular surface sensitivity. In this condition, mast cells release histamine and other inflammatory mediators, sensitizing corneal nerve endings and leading to itching, redness, and swelling. Instilling eye drops in the presence of allergic conjunctivitis can exacerbate these symptoms and trigger a more intense burning sensation. Certain preservatives or active ingredients within the eye drops may act as allergens, further amplifying the allergic response and increasing discomfort. Managing allergic conjunctivitis typically involves using antihistamine or mast cell stabilizer eye drops to control the allergic reaction and reduce ocular surface inflammation, thereby improving tolerability of other ophthalmic solutions.
In summary, the pre-existing condition of the ocular surface is a critical determinant of the burning sensation experienced upon eye drop instillation. Dry eye disease, blepharitis/MGD, corneal abrasions/defects, and allergic conjunctivitis all compromise the protective mechanisms of the ocular surface, increasing sensitivity and making patients more vulnerable to irritation from ophthalmic solutions. Recognizing and addressing these underlying conditions is essential in minimizing discomfort, improving treatment adherence, and optimizing therapeutic outcomes. The selection of appropriate eye drop formulations, including preservative-free options and lubricating agents, plays a crucial role in managing ocular surface sensitivity and alleviating burning sensations. This insight reinforces the understanding of “why does eye drops burn,” emphasizing the patient-specific nature of this common complaint.
6. Drop Viscosity
Viscosity, defined as a fluid’s resistance to flow, plays a significant role in ocular comfort and can influence the sensation of burning upon eye drop instillation. While not always a primary cause, viscosity interacts with other factors to modulate the overall experience. Increased viscosity can both alleviate and exacerbate discomfort depending on the specific formulation and the individual’s ocular surface condition. Formulations designed to prolong corneal contact time often employ viscosity-enhancing agents, which may, in some cases, lead to transient burning or blurring.
The mechanism by which viscosity affects comfort is multifaceted. Highly viscous drops can create a temporary blurring of vision immediately following instillation, which some individuals perceive as a stinging or burning sensation. Furthermore, thicker solutions can disrupt the tear film more significantly than less viscous ones, potentially leading to tear film instability and evaporative dry eye in susceptible individuals. However, increased viscosity can also provide a protective effect, shielding the corneal surface from irritants and reducing friction between the eyelid and the cornea. This is particularly beneficial for individuals with dry eye disease or other ocular surface disorders where the natural tear film is compromised. For example, lubricating eye drops with high viscosity can provide extended relief from dryness symptoms but may also cause temporary blurring or a foreign body sensation. The practical significance of this understanding lies in the careful balancing of viscosity to achieve optimal therapeutic efficacy and patient comfort.
In conclusion, drop viscosity is a relevant, albeit complex, factor influencing the sensation of burning experienced with eye drops. While high viscosity can offer protective and lubricating benefits, it can also contribute to blurring and tear film disruption, potentially exacerbating discomfort in certain individuals. Therefore, ophthalmic formulations must carefully consider the impact of viscosity alongside other factors such as pH, osmolarity, and preservative content to optimize tolerability and ensure patient compliance. Further research and development are needed to refine viscosity-enhancing agents that minimize adverse effects while maximizing therapeutic benefit, and it is an area of concern that relates to “why does eye drops burn”.
7. Instillation Technique
The method of administering ophthalmic solutions significantly impacts ocular comfort and can contribute to the sensation of burning or stinging. Even when the solution’s formulation is optimized for tolerability, improper instillation can trigger discomfort and compromise treatment efficacy. The technique employed directly affects the volume of solution delivered, the distribution across the ocular surface, and the potential for trauma to delicate tissues.
-
Forceful Application
Applying eye drops with excessive force can cause physical trauma to the cornea and conjunctiva. A forceful stream of liquid impacting the ocular surface can directly stimulate nerve endings, resulting in a stinging or burning sensation. Furthermore, this can lead to reflex blinking and tearing, washing away the medication before it has a chance to be absorbed. For example, squeezing the bottle too hard can propel a large droplet at high velocity, increasing the likelihood of discomfort. Proper instillation involves gently squeezing the bottle to release a single drop without contacting the eye directly, thus mitigating the risk of trauma-induced burning. This is significant because it directly affects how well the medication will work if the patient cannot tolerate the delivery due to the pain of forceful application.
-
Contamination and Contact
Allowing the eye drop bottle tip to contact the ocular surface or surrounding tissues introduces a risk of contamination. Contact with the eyelid, eyelashes, or skin can transfer bacteria and other microorganisms into the solution, potentially leading to infection. Furthermore, physical contact with the cornea can cause micro-abrasions, increasing sensitivity and making the eye more susceptible to irritation from the eye drop’s components. Patients should be instructed to avoid touching the bottle tip to any surface and to discard the bottle if contamination is suspected. The resultant irritation from contamination, even if subtle, contributes directly to the question of “why does eye drops burn”.
-
Excessive Dosage
Administering more than one drop at a time is generally unnecessary and can increase the likelihood of burning or stinging. The conjunctival sac has a limited capacity to hold fluid, and excess solution simply overflows onto the cheek. This not only wastes medication but also increases the exposure of the surrounding skin to potentially irritating preservatives and active ingredients. Furthermore, the excess fluid can disrupt the tear film, leading to temporary blurring and discomfort. Patients should be advised that one drop is typically sufficient to achieve the desired therapeutic effect and that additional drops will not enhance the medication’s efficacy. Too much fluid can also cause irritation or an allergic reaction on the cheek, which would contribute to the patient’s overall discomfort.
-
Incorrect Aim and Distribution
Improperly aiming the eye drop can result in the solution landing on the eyelid or surrounding skin rather than the ocular surface. This misdirection not only reduces the amount of medication delivered to the eye but also exposes the skin to potentially irritating components. Additionally, if the drop lands in the inner corner of the eye near the tear duct, it can be rapidly drained away, minimizing contact time with the cornea and conjunctiva. Patients should be instructed to tilt their head back, gently pull down the lower eyelid to create a small pocket, and aim the drop into this pocket without touching the eye with the bottle tip. This ensures that the solution is delivered directly to the ocular surface, maximizing its therapeutic effect and minimizing exposure to surrounding tissues. This accurate delivery, in conjunction with other improvements, will reduce the chance of burning, thereby decreasing the chances of a patient asking “why does eye drops burn”.
In summary, proper instillation technique is paramount in minimizing discomfort and optimizing the therapeutic benefit of ophthalmic solutions. Forceful application, contamination, excessive dosage, and incorrect aim can all contribute to the sensation of burning or stinging. Patient education and adherence to recommended instillation procedures are essential in mitigating these factors and ensuring successful treatment outcomes. Attention to these details transforms a potentially unpleasant experience into a manageable component of ophthalmic care.
Frequently Asked Questions
This section addresses commonly encountered questions regarding the stinging or burning sensation experienced upon instilling ophthalmic solutions. The information provided aims to clarify the underlying causes and potential management strategies.
Question 1: Is the burning sensation from eye drops always a cause for concern?
A transient burning sensation is a relatively common side effect, particularly with certain formulations. However, persistent or severe burning, accompanied by other symptoms such as redness, itching, or swelling, warrants prompt evaluation by an eye care professional.
Question 2: Are preservative-free eye drops always better for sensitive eyes?
Preservative-free formulations eliminate the potential for preservative-related irritation, which is a significant factor in many cases. However, the active ingredient itself can still cause discomfort in some individuals. A trial-and-error approach, under professional guidance, may be necessary to identify the most tolerable option.
Question 3: Can the technique of instilling eye drops influence the burning sensation?
Yes, improper instillation, such as forceful application or contamination of the bottle tip, can exacerbate discomfort. Adhering to recommended instillation techniques, including gentle application and avoiding contact with the ocular surface, is crucial.
Question 4: Does the pH of an eye drop directly correlate with the intensity of burning?
Generally, the greater the deviation of an ophthalmic solution’s pH from the natural tear film pH (approximately 7.4), the more intense the burning sensation is likely to be. However, other factors, such as osmolarity and the presence of irritating ingredients, also play a role.
Question 5: Can pre-existing eye conditions affect the tolerability of eye drops?
Indeed. Conditions such as dry eye disease, blepharitis, and corneal abrasions compromise the ocular surface, rendering it more susceptible to irritation from eye drop components. Addressing these underlying conditions can improve tolerability.
Question 6: How long should the burning sensation last after instilling eye drops?
A mild, transient burning sensation typically subsides within a few minutes. If the burning persists for an extended period or intensifies, immediate consultation with an ophthalmologist is recommended.
The sensation of burning upon eye drop instillation is often multifactorial, encompassing formulation characteristics, instillation technique, and individual ocular surface conditions. Awareness of these factors is paramount in mitigating discomfort and promoting treatment adherence.
The subsequent section will explore strategies for minimizing ocular discomfort associated with eye drop use.
Minimizing Discomfort
Addressing the common experience of burning upon eye drop instillation requires a multifaceted approach. These recommendations aim to mitigate discomfort and optimize treatment adherence.
Tip 1: Refrigerate Eye Drops (If Appropriate): Cooling eye drops, if the specific formulation allows, can reduce the stinging sensation. Cold temperatures may numb nerve endings, providing temporary relief. Consult the product information for specific refrigeration instructions as not all formulations are suitable for cold storage.
Tip 2: Occlude the Nasolacrimal Duct: Immediately after instilling eye drops, gently apply pressure to the inner corner of the eye (nasolacrimal duct) for one to two minutes. This reduces systemic absorption and minimizes drainage of the medication away from the ocular surface, increasing its effectiveness and potentially lessening irritation.
Tip 3: Use Artificial Tears Beforehand (If Recommended): For individuals prone to dry eye or ocular surface irritation, instilling artificial tears 5-10 minutes before applying prescription eye drops can provide a protective barrier. This may shield the cornea from potentially irritating components and enhance overall comfort.
Tip 4: Blink Gently and Avoid Squeezing Eyes Shut: After instilling a drop, blink gently to spread the medication evenly across the ocular surface. Avoid forcefully squeezing the eyes shut, as this can expel the solution and increase irritation.
Tip 5: Request Preservative-Free Formulations: When possible, request preservative-free versions of prescribed eye drops from the prescribing physician. Preservatives, particularly benzalkonium chloride (BAK), are a common source of ocular irritation. Preservative-free options can significantly improve tolerability, especially with long-term use. This is an important consideration that affects “why does eye drops burn”.
Tip 6: Administer Eye Drops Before Sleep: Some eye drops cause temporary blurring of vision. Applying these drops before bedtime allows the blurring to subside during sleep, minimizing daytime discomfort.
Tip 7: Warm Eye Drops to Body Temperature: If refrigerated drops are intolerable even when cold, try holding the closed bottle in closed hands for a few minutes prior to application in order to warm up to body temperature.
Adherence to these recommendations can significantly improve the experience of using eye drops, minimize the burning sensation, and promote consistent adherence to prescribed treatment regimens. This is important in maximizing patient tolerability and ensuring the therapeutic efficiency of the medication.
The following section concludes this article by summarizing the key aspects discussed and providing further recommendations.
Conclusion
The exploration of factors contributing to the stinging or burning sensation upon eye drop instillation has revealed a complex interplay of formulation properties, ocular surface conditions, and administration techniques. Key elements include pH and osmolarity imbalances, preservative sensitivity, active ingredient irritation, pre-existing ocular surface disease, drop viscosity, and instillation method. Each factor contributes uniquely to the overall discomfort experienced, highlighting the multifaceted nature of this common complaint.
Understanding these elements is crucial for optimizing patient comfort and ensuring adherence to prescribed ophthalmic treatments. Continued research into improved formulations, alternative preservatives, and enhanced delivery methods is essential to minimize ocular irritation and improve the overall patient experience. Addressing the issue of “why does eye drops burn” remains paramount to ensure effective treatment and maintain ocular health, as further innovation and patient education is always beneficial to eye medication tolerance.
